| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4002709 | American Journal of Ophthalmology | 2013 | 9 Pages |
Abstract
Intravitreal C3F8 injection could offer a minimally invasive alternative to PPV in patients with symptomatic and persistent vitreomacular traction. It appears particularly effective in eyes with less extensive vitreomacular traction and low vitreous face reflectivity on SD OCT. Further studies are warranted.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Ian A. Rodrigues, Alexandros N. Stangos, Dominic A. McHugh, Timothy L. Jackson,